MYORG

Chr 9AR

myogenesis regulating glycosidase

Also known as: IBGC7, KIAA1161, NET37

The protein is an alpha-galactosidase with unusual specificity for Gal-alpha1,4-Glc structures and promotes myogenesis by activating AKT signaling through IGF2 maturation and secretion. Mutations cause basal ganglia calcification, idiopathic, 7, which follows autosomal recessive inheritance. The gene shows very low constraint against loss-of-function variants (pLI near zero), suggesting haploinsufficiency is well-tolerated.

OMIMResearchSummary from RefSeq, OMIM, UniProt
ARLOEUF 1.341 OMIM phenotype
Clinical SummaryMYORG
Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint
1.34LOEUF
pLI 0.000
Z-score 0.40
OE 0.90 (0.621.34)
Tolerant

Highly tolerant — LoF variants common in population

Missense Constraint
1.39Z-score
OE missense 0.83 (0.770.90)
436 obs / 525.7 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios
LoF OE0.90 (0.621.34)
00.351.4
Missense OE0.83 (0.770.90)
00.61.4
Synonymous OE1.00
01.21.6
LoF obs/exp: 18 / 19.9Missense obs/exp: 436 / 525.7Syn Z: 0.03

ClinVar Variant Classifications

0 submitted variants in ClinVar

Protein Context — Lollipop Plot

MYORG · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

3D Protein StructureAlphaFold

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →